Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Therapeutic Radioisotopes Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Therapeutic Radioisotopes Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Therapeutic Radioisotopes Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Type
    • 1.4.2 Radium-223
    • 1.4.3 Lutetium-177
    • 1.4.4 Iodine-131
    • 1.4.5 Other
  • 1.5 Market by Application
    • 1.5.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Application
    • 1.5.2 Thyroid
    • 1.5.3 Bone Metastasis
    • 1.5.4 Lymphoma
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Therapeutic Radioisotopes Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Therapeutic Radioisotopes Industry
      • 1.6.1.1 Therapeutic Radioisotopes Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Therapeutic Radioisotopes Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Therapeutic Radioisotopes Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Therapeutic Radioisotopes Market Size Estimates and Forecasts
    • 2.1.1 Global Therapeutic Radioisotopes Revenue 2015-2026
    • 2.1.2 Global Therapeutic Radioisotopes Sales 2015-2026
  • 2.2 Therapeutic Radioisotopes Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Therapeutic Radioisotopes Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Therapeutic Radioisotopes Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Therapeutic Radioisotopes Competitor Landscape by Players

  • 3.1 Therapeutic Radioisotopes Sales by Manufacturers
    • 3.1.1 Therapeutic Radioisotopes Sales by Manufacturers (2015-2020)
    • 3.1.2 Therapeutic Radioisotopes Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Therapeutic Radioisotopes Revenue by Manufacturers
    • 3.2.1 Therapeutic Radioisotopes Revenue by Manufacturers (2015-2020)
    • 3.2.2 Therapeutic Radioisotopes Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Therapeutic Radioisotopes Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Therapeutic Radioisotopes Revenue in 2019
    • 3.2.5 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Therapeutic Radioisotopes Price by Manufacturers
  • 3.4 Therapeutic Radioisotopes Manufacturing Base Distribution, Product Types
    • 3.4.1 Therapeutic Radioisotopes Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Therapeutic Radioisotopes Product Type
    • 3.4.3 Date of International Manufacturers Enter into Therapeutic Radioisotopes Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Therapeutic Radioisotopes Market Size by Type (2015-2020)
    • 4.1.1 Global Therapeutic Radioisotopes Sales by Type (2015-2020)
    • 4.1.2 Global Therapeutic Radioisotopes Revenue by Type (2015-2020)
    • 4.1.3 Therapeutic Radioisotopes Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Therapeutic Radioisotopes Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Therapeutic Radioisotopes Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Type (2021-2026)
    • 4.2.3 Therapeutic Radioisotopes Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Therapeutic Radioisotopes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Therapeutic Radioisotopes Market Size by Application (2015-2020)
    • 5.1.1 Global Therapeutic Radioisotopes Sales by Application (2015-2020)
    • 5.1.2 Global Therapeutic Radioisotopes Revenue by Application (2015-2020)
    • 5.1.3 Therapeutic Radioisotopes Price by Application (2015-2020)
  • 5.2 Therapeutic Radioisotopes Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Therapeutic Radioisotopes Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Therapeutic Radioisotopes Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Therapeutic Radioisotopes by Country
    • 6.1.1 North America Therapeutic Radioisotopes Sales by Country
    • 6.1.2 North America Therapeutic Radioisotopes Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Therapeutic Radioisotopes Market Facts & Figures by Type
  • 6.3 North America Therapeutic Radioisotopes Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Therapeutic Radioisotopes by Country
    • 7.1.1 Europe Therapeutic Radioisotopes Sales by Country
    • 7.1.2 Europe Therapeutic Radioisotopes Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Therapeutic Radioisotopes Market Facts & Figures by Type
  • 7.3 Europe Therapeutic Radioisotopes Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Therapeutic Radioisotopes by Region
    • 8.1.1 Asia Pacific Therapeutic Radioisotopes Sales by Region
    • 8.1.2 Asia Pacific Therapeutic Radioisotopes Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Type
  • 8.3 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Therapeutic Radioisotopes by Country
    • 9.1.1 Latin America Therapeutic Radioisotopes Sales by Country
    • 9.1.2 Latin America Therapeutic Radioisotopes Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Therapeutic Radioisotopes Market Facts & Figures by Type
  • 9.3 Central & South America Therapeutic Radioisotopes Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Therapeutic Radioisotopes by Country
    • 10.1.1 Middle East and Africa Therapeutic Radioisotopes Sales by Country
    • 10.1.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Type
  • 10.3 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description, Business Overview and Total Revenue
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Therapeutic Radioisotopes Products Offered
    • 11.1.5 Bayer Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description, Business Overview and Total Revenue
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Therapeutic Radioisotopes Products Offered
    • 11.2.5 Novartis Recent Development
  • 11.3 China Isotope & Radiation
    • 11.3.1 China Isotope & Radiation Corporation Information
    • 11.3.2 China Isotope & Radiation Description, Business Overview and Total Revenue
    • 11.3.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 China Isotope & Radiation Therapeutic Radioisotopes Products Offered
    • 11.3.5 China Isotope & Radiation Recent Development
  • 11.4 Dongcheng
    • 11.4.1 Dongcheng Corporation Information
    • 11.4.2 Dongcheng Description, Business Overview and Total Revenue
    • 11.4.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Dongcheng Therapeutic Radioisotopes Products Offered
    • 11.4.5 Dongcheng Recent Development
  • 11.5 Q BioMed
    • 11.5.1 Q BioMed Corporation Information
    • 11.5.2 Q BioMed Description, Business Overview and Total Revenue
    • 11.5.3 Q BioMed Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Q BioMed Therapeutic Radioisotopes Products Offered
    • 11.5.5 Q BioMed Recent Development
  • 11.6 Curium Pharmaceuticals
    • 11.6.1 Curium Pharmaceuticals Corporation Information
    • 11.6.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.6.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Products Offered
    • 11.6.5 Curium Pharmaceuticals Recent Development
  • 11.7 Jubilant DraxImage
    • 11.7.1 Jubilant DraxImage Corporation Information
    • 11.7.2 Jubilant DraxImage Description, Business Overview and Total Revenue
    • 11.7.3 Jubilant DraxImage Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Jubilant DraxImage Therapeutic Radioisotopes Products Offered
    • 11.7.5 Jubilant DraxImage Recent Development
  • 11.8 Lantheus
    • 11.8.1 Lantheus Corporation Information
    • 11.8.2 Lantheus Description, Business Overview and Total Revenue
    • 11.8.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Lantheus Therapeutic Radioisotopes Products Offered
    • 11.8.5 Lantheus Recent Development
  • 11.9 Spectrum Pharmaceuticals
    • 11.9.1 Spectrum Pharmaceuticals Corporation Information
    • 11.9.2 Spectrum Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.9.3 Spectrum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Products Offered
    • 11.9.5 Spectrum Pharmaceuticals Recent Development
  • 11.10 Progenics Pharmaceuticals
    • 11.10.1 Progenics Pharmaceuticals Corporation Information
    • 11.10.2 Progenics Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.10.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Products Offered
    • 11.10.5 Progenics Pharmaceuticals Recent Development
  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description, Business Overview and Total Revenue
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Therapeutic Radioisotopes Products Offered
    • 11.1.5 Bayer Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Therapeutic Radioisotopes Market Estimates and Projections by Region
    • 12.1.1 Global Therapeutic Radioisotopes Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Therapeutic Radioisotopes Revenue Forecast by Regions 2021-2026
  • 12.2 North America Therapeutic Radioisotopes Market Size Forecast (2021-2026)
    • 12.2.1 North America: Therapeutic Radioisotopes Sales Forecast (2021-2026)
    • 12.2.2 North America: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
    • 12.2.3 North America: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Therapeutic Radioisotopes Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Therapeutic Radioisotopes Sales Forecast (2021-2026)
    • 12.3.2 Europe: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Therapeutic Radioisotopes Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Therapeutic Radioisotopes Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Therapeutic Radioisotopes Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Therapeutic Radioisotopes Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Therapeutic Radioisotopes Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Therapeutic Radioisotopes Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Therapeutic Radioisotopes Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Therapeutic Radioisotopes Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Therapeutic Radioisotopes Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Therapeutic Radioisotopes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Radioisotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Therapeutic Radioisotopes market is segmented into
    Radium-223
    Lutetium-177
    Iodine-131
    Other

    Segment by Application, the Therapeutic Radioisotopes market is segmented into
    Thyroid
    Bone Metastasis
    Lymphoma
    Other

    Regional and Country-level Analysis
    The Therapeutic Radioisotopes market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Therapeutic Radioisotopes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Therapeutic Radioisotopes Market Share Analysis
    Therapeutic Radioisotopes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Therapeutic Radioisotopes business, the date to enter into the Therapeutic Radioisotopes market, Therapeutic Radioisotopes product introduction, recent developments, etc.
    The major vendors covered:
    Bayer
    Novartis
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes

    Buy now